Envoplakin Antikörper (AA 1275-1325)
-
- Target Alle Envoplakin (EVPL) Antikörper anzeigen
- Envoplakin (EVPL)
-
Bindungsspezifität
- AA 1275-1325
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Envoplakin Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Verwendungszweck
- Rabbit anti-EVPL Antibody, Affinity Purified
- Aufreinigung
- Affinity Purified
- Immunogen
- Between AA 1275 and 1325
- Isotyp
- IgG
- Top Product
- Discover our top product EVPL Primärantikörper
-
-
- Applikationshinweise
- 1:2,000 - 1:10,000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 1000 μg/mL
- Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Haltbarkeit
- 12 months
-
- Target
- Envoplakin (EVPL)
- Andere Bezeichnung
- EVPL (EVPL Produkte)
- Hintergrund
- Background: Envoplakin is a member of the plakin family of proteins that forms a component of desmosomes and the epidermal cornified envelope. The gene is located in the tylosis oesophageal cancer locus on chromosome 17q25, and its deletion is associated with both familial and sporadic forms of oesophageal squamous cell carcinoma. Patients suffering from the autoimmune mucocutaneous disorder, paraneoplastic pemphigus, develop antibodies against Envoplakin [taken from NCBI Entrez Gene (Gene ID: 2125)].
- Gen-ID
- 2125
- UniProt
- Q92817
-